FSD Pharma : Submits a Phase-1 Multiple Ascending Doses Clin

FSD Pharma : Submits a Phase-1 Multiple Ascending Doses Clinical Trial Application for Lucid-21-302 (Lucid-MS) for Ethics Committee Review in Australia - Form 6-K

FSD Pharma : Submits a Phase-1 Multiple Ascending Doses Clinical Trial Application for Lucid-21-302 (Lucid-MS) for Ethics Committee Review in Australia - Form 6-K

marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

Toronto , Ontario , Canada , Australia , Canadian , Andrzej Chruscinski , Zeeshan Saeed , Ethics Committee , Clinical Affairs , Pharma Inc , Celly Nutrition Corp , Nasdaq , Lucid Psycheceuticals Inc , Strategic Investments Inc , Company Annual Report On Form , Ascending Doses Clinical , Ethics Committee Review , Multiple Ascending Dose Study , Healthy Adult Participants , New Chemical Entity , Lucid Psycheceuticals , Celly Nutrition , Investments Inc , Classb Shares , Canadian Securities Administrators , Annual Report , Registration Statement , Executive Co Chairman ,